Social Adjustment: Clinical Trials

3 trials for Social Adjustment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 21Completed 1

Follow Social Adjustment: new trials by email Literature Review of Social Adjustment trials Research Report on Social Adjustment

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Differences in Schizophrenia With One-month and 3-month Paliperidone Palmitate Treatment
Paliperidone Palmitate 156 MG/ML Prefilled Syringe [Invega], Paliperidone Palmitate 546 MG Intramuscular Suspension, Extended Release [INVEGA TRINZA] - Schizophrenics
Phase 1 / Phase 2CompletedCalo Psychiatric Center722015-01-012021-02-15
Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia
Intranasal Oxytocin Spray - Schizophrenia, Schizoaffective Disorder
Phase 1CompletedUniversity of North Carolina, Chapel Hill682011-07-012015-06-11
Pilot Program for Targeted Prevention of Child or Adolescent Weight Gain
Interpersonal Psychotherapy - Overweight Adolescents, Overweight
Phase 1CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1472005-12-052017-10-06

Narrower conditions

Bulimia (1)  ·  Feeding and Eating Disorders (1)  ·  Obesity (1)  ·  Overweight (1)  ·  Paranoid Disorders (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)

Broader conditions

Behavior (3)  ·  Social Behavior (3)  ·  Mental Disorders (2)  ·  Body Weight (1)  ·  Hyperphagia (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Overnutrition (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Digestive (1)

Interventions

Interpersonal Psychotherapy (1)  ·  Paliperidone Palmitate (1)

Sponsors

Calo Psychiatric Center (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (2)

Top investigators

Cort A Pedersen, MD (1)  ·  David L Penn, PhD (1)  ·  For-Wey Lung, MD, ScD (1)  ·  Jack A Yanovski, M.D. (1)

Results publications

PMID 26210388, PMID 28714097, PMID 36931838, PMID 38271099

NIH funding

R01MH093529 (1)